1 completed, 1 unknown. 1 Not applicable, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Unknown 1 |
| Phase 1 | 1 | Completed 1 |
Follow Salt Tablets: new trials by email Literature Review of Salt Tablets trials Research Report on Salt Tablets
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Fluid Loading Countermeasures Salt Tablets, Electrolyte Solution - Healthy | Not applicable | Unknown | National Aeronautics and Space Administration (NASA) | 15 | 2022-04-01 | 2024-07-10 |
| Selinexor (KPT-330) in Combination With Temozolomide and Radiation Therapy in Patients With Newly Diagnosed Glioblastoma Selinexor, Temozolomide, Generic Radiation therapy (RT) - Gliosarcoma, Newly Diagnosed | Phase 1 | Completed | National Cancer Institute (NCI) | 11 | 2020-07-07 | 2026-10-27 |
Glioblastoma (1) · Gliosarcoma (1)
National Aeronautics and Space Administration (NASA) (1) · National Cancer Institute (NCI) (1)
United States (2)
Jason R. Lytle, PhD (1) · Kevin A Camphausen, M.D. (1)